Trial Profile
Pharmacokinetics, pharmacodynamics, and tolerability of clevidipine in patients with mild to moderate essential hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2012
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 01 Jun 2012 New trial record